Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

Completed · Phase 2 · Has a placebo group

Conditions studied: Bipolar Disorder, Mania, Bipolar Depression

In brief

The purpose of this study is to determine whether the amino acid taurine has effects on mood stability in bipolar disorder.

Key facts

Study ID

NCT00217165

Run by

Mclean Hospital

People needed

60

Starts

2005-04-01

Expected to finish

2011-12-01

Last updated by the study team

2019-03-01

Who can join

Age: 18 and older, up to 68. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• bipolar disorder, type I bipolar disorder, type II mania hypomania mixed manic symptoms

You may not qualify if…

• significant medical or psychiatric co-morbidity pregnancy or planning pregnancy current substance abuse or dependence

Where it is running

• McLean Hospital — Belmont, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.